Executing a national women’s-health rollout demands deep clinical, healthcare-operations, financial and commercial leadership, supported by a governance framework appropriate to a regulated healthcare business and to institutional and development-finance investors.
Leadership structure
|
Role |
Mandate |
|---|---|
|
Chief Executive Officer |
Strategy, funding, brand & medical-aid relationships |
|
Chief Medical / Clinical Officer |
Clinical governance, protocols, quality & specialist leadership |
|
Chief Operating Officer |
Rollout, clinic operations, hospital partnerships & procurement |
|
Chief Financial Officer |
Finance, treasury, revenue-cycle & investor reporting |
|
Head of People & Recruitment |
Specialist recruitment & retention — a board-level priority |
|
Head of Technology & Digital |
LumaVida App, EMR, membership platform & data |
Governance framework
A board with independent representation oversees management through clinical-governance, audit-and-risk, and social-and-ethics committees. The framework covers patient safety and clinical quality, HPCSA and regulatory compliance, medical-aid and billing integrity, data privacy, B-BBEE, and the covenant and reporting obligations attached to the funding. Given the centrality of specialist recruitment, people and clinical leadership are elevated to board-level priorities.
|
Committee |
Mandate |
Cadence |
|---|---|---|
|
Board |
Strategy, capital, rollout, appointments |
Quarterly |
|
Clinical governance |
Credentialing, outcomes, patient safety |
Quarterly |
|
Audit & risk |
Controls, billing integrity, covenants, liquidity |
Quarterly |
|
Social & ethics |
Access, B-BBEE, data privacy, community |
Half-yearly |